Skip to content

Public FDA record

Z-2377-2018: Medtronic MiniMed Paradigm Veo Insulin Pump Product Catalog Number: MMT-554, MMT-754

Recall record Z-2377-2018 for Medtronic Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2377-2018
Company in FDA record
Medtronic Inc.
FDA classification date
Jul 5, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The MiniMed Paradigm Veo insulin pump has an error that impacts the Arabic language translation.This translation error occurs in the Predictive Alerts setting screen, which allows user to program alerts that will sound if users are predicted to reach their pre-set low or high sensor glucose values.

Source facts

Action
Medtronic Inc. conducted this field corrective action via Urgent Field Safety Notification to customers: patients and health care providers.
Initiated
2018-04-24
Root cause
Under Investigation by firm
Terminated
2022-05-02
Distribution
International only. No U.S. distribution
Recall number
Z-2377-2018
Recall status
Terminated
CDRH record ID
165197
FDA classified
2018-07-05
Recall event number
80320

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗